ADMA - Latest News

ADMA Biologics, Inc. (ADMA), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $2.40B. Trailing twelve-month P/E ratio is 13.97. Beta to the broader market is 0.77.

The article list below shows the most recent ADMA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ADMA Headlines

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

globenewswire.com - Oct 15, 2026

Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG Yield

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

zacks.com - Oct 12, 2026

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports a

ADMA Biologics (NASDAQ:ADMA) & Myriad Genetics (NASDAQ:MYGN) Critical Analysis

defenseworld.net - Oct 12, 2026

Myriad Genetics (NASDAQ: MYGN - Get Free Report) and ADMA Biologics (NASDAQ: ADMA - Get Free Report) are both healthcare companies, but which is the b

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

zacks.com - Oct 8, 2026

In the latest trading session, Adma Biologics (ADMA) closed at $10. 33, marking a +1.

ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know

zacks.com - Oct 8, 2026

Recently, Zacks. com users have been paying close attention to Adma Biologics (ADMA).

How News Affects ADMA Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ADMA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ADMA news questions

What is the latest ADMA news headline?

The most recent ADMA headline (Oct 15, 2026) is "ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ADMA news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ADMA news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ADMA options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.